Prospective Multicenter Study on Clinical Application of Sonazoid in Breast Tumor - Trial NCT04657328
Access comprehensive clinical trial information for NCT04657328 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese PLA General Hospital and is currently Recruiting. The study focuses on Ultrasound. Target enrollment is 181 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Chinese PLA General Hospital
Timeline & Enrollment
N/A
Aug 15, 2020
Oct 01, 2021
Primary Outcome
Diagnostic performance of contrast-enhanced ultrasound in breast tumor by Sonazoid.
Summary
Sonazoid as a new generation of ultrasound contrast agent.This study based on the features of
 Sonazoid specific angiography and high mechanical index,the role of Sonazoid in the
 differential diagnosis of breast benign and malignant tumors was explored.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04657328
Non-Device Trial